Drug
Ionis FB Lrx
Ionis FB Lrx: highest development phase Phase 2, developed by Ionis Pharmaceuticals. 2 trial records tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Ionis Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| IONIS-FB-Lrx NCT03446144 | Phase 2 | Geographic Atrophy |
| IONIS-FB-LRx NCT04014335 | Phase 2 | Primary IgA Nephropathy |
Latest
No recent events.
Follow Ionis FB Lrx on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.